| Sunday, May 16 | Monday, May 17 | Tuesday, May 18 |
| FC1 | FC8 | FC16 |
| FC2 | FC9 | FC17 |
| FC3 | FC10 | FC18 |
| FC4 | FC11 | FC19 |
| FC5 | FC12 | |
| FC6 | FC13 | |
| FC7 | FC14 | |
| FC15 |
Sunday, May 16
Free Communication Session 1 |
Vascular damage in ESRD |
Chair: A. Covic, Iasi, Romania and L. Del Vecchio, Lecco, Italy |
WHICH IS THE BEST INFLAMMATION MARKER? A COMPARATIVE STUDY BASED ON MULTIVARIATE MODELLING OF MORTALITY IN END STAGE RENAL DISEASE (ESRD) PATIENTS |
| Giovanni Tripepi, Francesca Mallamaci, Sebastiano Cutrupi, Patrizia Pizzini, Carmine Zoccali. |
| CNR-IBIM, National Research Council - Institute of Biomedicine, Clinical Epidemiology and Physiopathology of Renal Disease and Hypertension, Reggio Calabria, Italy |
CHRONIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION AS A POSSIBLE EXPLANATION FOR CHRONIC HYPOTENSION IN HEMODIALYSIS |
Elisabeth Coll,1 Maria Larrouse,2 Josep Lopez-Pedret,1 Alex De la Sierra,2 Aleix Cases.1 |
1Nephrology Unit, Hospital Clinic, Barcelona, Spain; 2Hypertension Unit, Hospital Clinic, Barcelona, Spain; Barcelona, Spain |
EFFECT OF HEPARIN AND DALTEPARIN ON LIPID PEROXIDATION IN ESRD PATIENTS ON HEMODIALYSIS |
Amir Ahmad Nassiri,1 Amir Hassan Nassiri,2 Mehrdad Solati,3 Mehdi Jalili,1 Firouz Fassihi,1 Ali Nobakht Haghighi,1 Khosrow Rahbar,1 Fereidoun Azizi.3 |
1Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Cardiopulmonary, Cardiopulmonary Hospital, Claud Bernard University, Lyon 1, Lyon, France; 3Endocrine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran |
ANTIOXIDANT AND HYPOLIPEMIC PROPERTIES OF RED GRAPE JUICE IN UREMIA |
Rocio Echarri,1 Patricia Castilla,2 M. Carmen Alarcon,1 Jose Luis Teruel,1 Miriam Lopez,1 Cristina Galeano,1 Miguel Angel Lasuncion,2 Joaquin Ortuno.1 |
1Nephrology, Hospital Ramon y Cajal, Madrid, Spain; 2Biochemistry, Hospital Ramon y Cajal, Madrid, Spain |
VITAMIN E AND CAROTID INTIMA-MEDIA THICKNESS PROGRESSION IN ENDSTAGE RENAL DISEASE (VIPER) |
Mona Boaz,1 Shmuel Smetana,2 Uzi Gafter,3 Luigi Iuliano,4 Tali Weinstein.3 |
1Epidemiology Unit, 2Institute of Nephrology, E. Wolfson Medical Center, Holon, Israel; 3Department of Nephrology, Golda Campus, Rabin Medical Center, Petah Tikvah, Israel; 4Department of Internal Medicine, La Sapienza University, Rome, Italy |
LONG-TERM TREATMENT OF HYPERHOMOCYSTEINEMIA PREVENTS CAROTID ARTERY ATHEROSCLEROSIS IN HAEMODIALYSED PATIENTS |
Carmelo Libetta,1 Riccardo Corbetta,2 Manuela Zucchi,1 Elena Gori,1 Giuseppe Villa,3 Vincenzo Sepe,1 Stefano Pirrelli,2 Giulietta Bezoari,1 Antonio Dal Canton.1 |
1Unit Nephrology, Dialysis and Transplantation, Univ & IRCCS Policlinico San Matteo, Pavia, Italy; 2Unit Vascular Surgery, IRCCS Policlinico San Matteo, Pavia, Italy; 3Div Nephrology, IRCCS Fondazione S. Maugeri, Pavia, Italy |
| back to the top |
| HALL 2.Baixa 09:00 - 10:30 |
| Free Communication Session 2 |
| Transplantation (1) |
| Chair: C. Newstead, Leeds, United Kingdom and M. Klinger, Wroclaw, Poland |
| THE ASSOCIATION OF RAPAMYCIN WITH FK506 OR CYCLOSPORINE INDUCE DIFFERENT FUNCTIONAL AND STRUCTURAL PATTERN OF NEPHROTOXICITY |
| Nuria Lloberas,1 Gabriela Alperovich,1,2 Joan Torras,1,2 Immaculada Herrero-Fresneda,1 Josep M. Cruzado,1,2 Marcel la Franquesa,1 Nuria Bolaños,1 Josep M. Grinyo.1,2 |
| 1Nephrology Laboratory, Hospital Universitari de Bellvitge, UB, L’Hospitalet del Llobregat, Barcelona, Spain; 2Nephrology Service, Hospital Universitari de Bellvitge, L’Hospitalet del Llobregat, Barcelona, Spain |
| GENE THERAPY WITH HEPATOCYTE GROWTH FACTOR ATTENUATES THE PROGRESSION OF CHRONIC ALLOGRAFT NEPHROPATHY |
| Immaculada Herrero-Fresneda,1 Joan Torras,1 Marcella Franquesa,1 August Vidal,2 Josep M. Cruzado,1 Nuria Lloberas,1 Cristina Fillat,3 Nuria Bolaños,1 Josep M. Grinyo.1 |
| 1Laboratory Experimental Nephrology, Hospital Universitari Bellvitge, L’Hospitalet, Barcelona, Spain; 2Pathology Serv, Hospital Universitari Bellvitge, L’Hospitalet, Barcelona, Spain; 3Centre Regulacio Genomica, Barcelona, Spain |
| RENAL PROTECTIVE EFFECTS OF LEUKOTRIENE RECEPTOR BLOCKERS IN A RAT MODEL OF CYCLOSPORINE NEPHROTOXICITY |
| Aydin Atakan,1 Beyza Macunluoglu,1 Leyla Citlak,2 Gozde Ulfer,3 Fulya Cakalagaoglu,2 Serhan Tuglular,4 Cetin Ozener,4 Emel Akoglu.4 |
| 1Internal Medicine, 2Pathology, 3Biochemistry, 4Nephrology, Marmara University School of Medicine, Istanbul, Turkey |
| EFFECTS OF IMMUNOSUPPRESSANTS ON NK CELLS |
| Maria Luisa Vampa,1 Robert W. Vaughan,2 Steven H. Sacks,1 Wilson Wong.1 |
| 1Nephrology and Transplantation, Guy’s Hospital, London, United Kingdom; 2Clinical Transplantation Laboratories, Guy’s Hospital, London, United Kingdom |
| DONOR PRE-TREATMENT WITH ATORVASTATIN UP-REGULATES HEME-OXYGENASE 1 IN RENAL TISSUE AND PREVENTS COLD PRESERVATION INJURY IN ISOGENEIC KIDNEY TRANSPLANTATION IN RATS |
| Uwe Goettmann, Paul Brinkkoetter, Christian Karle, Benito Yard, Fokko J. van der Woude, Claude Braun. |
| Vth Department of Medicine, University Hospital Mannheim, Mannheim, Germany |
| QUANTITATIVE ANALYSIS OF FRACTALKINE USING LASER MICRODISSECTION IN BIOPSIES FROM KIDNEY ALLOGRAFTS SHOWING SIGNS OF ACUTE REJECTION |
| Miriam C. Pietrzyk,1 Bernhard Banas,1 Konrad Wolf,1 Matthias Woenkhaus,2 Michael Fischereder,1 Bernhard K. Kramer.1 |
| 1Klinik und Poliklinik Innere Medizin II, Universitat Regensburg, Regensburg, Germany; 2Institut fur Pathologie, Universitat Regensburg, Regensburg, Germany |
| back to the top |
| HALL 4.Rossio 09:00 - 10:30 |
| Free Communication Session 3 |
| Diagnostic problems in CKD |
| Chair: V.E. Andreucci, Naples, Italy and P. Barceló, Barcelona, Spain |
| ESTIMATION OF THE PROTEIN/CREATININE RATIO (P/CR) IN A RANDOM URINE SAMPLE (RUS) FOR QUANTITIVE EVALUATION OF 24-HOURS PROTEIN EXCRETION (PRE) |
| Spiridon Michail,1 Dimitrios Stamatiades,1 George Vaiopoulos,2 George Kosmadakis,1 Despoina Smirloglou,1 Athina Gobou,1 Vasilios Filiopoulos,1 Christodoulos Georgoulias,1 Theodoros Draganis,1 Charalambos P. Stathakis.1 |
| 1Dept of Nephrology Gr. Vosnides, Laiko Hospital, Athens, Greece; 2First Department of Internal Medicine, University of Athens, Medical School, Athens, Greece |
| GLOMERULAR FILTRATION RATE CAN BE ESTIMATED FROM BODY CELL MASS AND PLASMA CREATININE: COMPARISON WITH OTHER PREDICTION FORMULAS |
| Carlo Donadio, Cristina Consani, Michela Ardini, Giada Bernabini, Francesca Caprio, Giulia Grassi. |
| Internal Medicine - Nephrology, University of Pisa, Pisa, Italy |
| PREDICTION OF GLOMERULAR FILTRATION RATE (GFR) USING BIOIMPEDANCE ANALYSIS (BIA) |
| Eun Kyoung Lee, Su Hee Kim, Jai Won Chang, Won Seok Yang, Soon Bae Kim, Sang Koo Lee, Su-Kil Park, Jung Sik Park. |
| Department of Internal Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea |
| SERUM CYSTATIN C: A SENSITIVE MARKER FOR EVALUATION OF GLOMERULAR FILTRATION RATE (GFR) IN HEPATORENAL SYNDROME |
| Ayman El-Baz,1 Amgad El-Agroudy,2 Hosam Ghanem,3 Mahmoud Yousef,4 Mohamed Abd El-Hamid,4 Abd El-Rahman Mokhtar.4 |
| 1Medical Biochemistry, Fac Medicine, 2Nephrology, Urology & Nephrology Center, 3Clinical Pathology, Fac Medicine, 4Internal Medicine, Fac Medicine, Mansoura University, Mansoura, Egypt |
| SIMPLE FORMULA FOR GLOMERULAR FILTRATION RATE EVALUATION FROM SERUM CYSTATIN C LEVEL |
| Miluse Hertlova,1 Hana Novotna,2 Ivo Hertl.3 |
| 1Dialysis Centre, University Hospital Brno, Brno, Czech Republic; 2Clinical Biochemistry, University Hospital Brno, Brno, Czech Republic; 3Faculty of Electrical Engineering and Communication, Brno University of Technology, Brno, Czech Republic |
| SCREENING FOR CKD IN THE GENERAL POPULATION IS UNNECESSARY BECAUSE MUCH OF THE DATA ALREADY EXISTS. EARLY RESULTS FROM THE NEOERICA PROJECT |
| Paul Stevens,1 Christopher Farmer,1 Simon de Lusignan,2 Tom Chan,2 Mel Walker,3 Donal O’Donoghue.4 |
| 1Renal Medicine, Kent and Canterbury Hosp, Canterbury, UK; 2Primary Care Informatics, Dept Community Health Sciences, St George’s Hosp Medical School, London, UK; 3Healthcare Management, Roche Products Ltd, Welwyn Garden City, UK; 4Renal Medicine, Hope Hospital, Salford, United Kingdom |
| back to the top |
| HALL 2.Baixa 13:30 - 15:00 |
| Free Communication Session 4 |
| Hypertension: clinical studies |
| Chair: K. Serdengecti, Istanbul, Turkey and G. London, Fleury-Merogis, France |
| DO MICROELEMENTS MODIFY THE ACTIVITY OF SOME SODIUM TRANSPORTING SYSTEMS IN ERYTHROCYTE MEMBRANES OF PATIENTS WITH ESSENTIAL HYPERTENSION? |
| Karolina Kedzierska,1 Joanna Bober,2 Ewa Kwiatkowska,1 Edyta Golembiewska,1 Iwona Nocen,2 Leszek Domanski,1 Jacek Rozanski,1 Violetta Bielicka,1 Kazimierz Ciechanowski.1 |
| 1Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland; 2Department of Biochemistry and Chemistry, Pomeranian Medical University, Szczecin, Poland |
| SLEEP APNEA SYNDROME; A CAUSATIVE FACTOR OF NOCTURNAL MICROALBUMINURIA |
| Christos Liavvas,1 Emmanouil Vlachogiannis,1 Euphemia Daskalopoulou,1 Chrysoula Kourtidou-Papadeli,1 Nicholas Dombros.2 |
| 1Internal Medicine, Sleep Laboratory, St. Paul General Hospital, Thessaloniki, Greece; 2Internal Medicine, Aristotle University, Thessaloniki, Greece |
| THE EFFECT OF ANTIHYPERTENSIVE AGENTS ON PLASMA ADIPONECTIN LEVELS IN ESSENTIAL HYPERTENSION |
| Mahmut Ilker Yilmaz, Alper Sonmez, Mujdat Yenicesu, Kayser Caglar, Tayfun Eyileten, Yusuf Oguz, Izzet Yavuz, Abdulgaffar Vural. |
| Nephrology, Gulhane School of Medicine, Ankara, Turkey |
| PREVALENCE OF RENAL FUNCTION DERANGEMENT IN THE GENERAL POPULATION |
| Alessandra Sturani,1 Maria Grazia Puglia,2 Mirko Di Martino,2 Francesca Baiardi,2 Maurizio Fusaroli,1 Ezio Degli Esposti.3 |
| 1Department of Nephrology and Dialysis, Santa Maria delle Croci Hospital, Ravenna, Italy; 2CliCon Srl, Health Economics and Outcomes Research, Ravenna, Italy; 3Clinical Effectiveness Unit, Local Health Unit, Ravenna, Italy |
| A NEW TEST TO PREDICT THE EFFECT OF RENAL REVASCULARIZATION ON RENAL FUNCTION IN PATIENTS WITH RENAL ARTERY STENOSIS AND RENAL INSUFFICIENCY |
| Alessandro Zuccalà,1 Francesco Losinno,2 Emanuele Mambelli,1 Antonio Santoro.1 |
| 1Nephrology and Urology, Unit of Nephrology-Malpighi, Policlinico S.Orsola-Malpighi, Bologna, Italy; 2Radiology, Policlinico S.Orsola-Malpighi, Bologna, Italy |
| EOSINOPHILIA - A NOVEL PREDICTOR OF MORTALITY IN ATHEROSCLEROTIC RENAL ARTERY DISEASE |
| Samira Siddiqui,1 Mark S. MacGregor,1 Catherine Glynn,2 Giles Roditi,2 Christopher J. Deighan.1 |
| 1Renal Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom; 2Radiology Department, Glasgow Royal Infirmary, Glasgow, United Kingdom |
| back to the top |
| HALL 3.Lapa 16:00 - 17:30 |
| Free Communication Session 5 |
| Vitamin D and PTH |
| Chair: M. Ketteler, Aachen, Germany and E. Slatopolski, St. Louis, USA |
| REGULATION OF PARATHYROID EXPRESSION OF ACTIVATOR PROTEIN 2 (AP2), A KNOWN ACTIVATOR OF TGFa/EGFR GENE TRANSCRIPTOR, BY PHOSPHORUS, CALCIUM, AND VITAMIN D IN UREMIC RATS |
| Mario Cozzolino,1,2 Diego Brancaccio,1 Maurizio Gallieni,1 Eduardo Slatopolsky,2 Adriana Dusso.2 |
| 1Renal Division, San Paolo Hospital, Milan, Italy; 2Renal Division, Washington University, St. Louis, MO, United States |
| ASSOCIATION OF ELEVATED SERUM PARATHYROID HORMONE (PTH) AND CALCIUM WITH RISK OF HIP, VERTEBRAL OR PELVIC FRACTURE IN HEMODIALYSIS PATIENTS |
| John Kim,1 Michelle Dylan,2 Quan Doan,2 Robert Griffiths,3 Catherine Stehman-Breen,1 Robert Dubois,2 Mark Danese.1 |
| 1Amgen, Thousand Oaks, CA, United States; 2Zynx Health, Beverly Hills, CA, United States; 3Health Economics Consulting, Annapolis, MD, United States |
| DIFFERENTIAL EXPRESSION PATTERNS OF DIFFUSE AND NODULAR REFRACTORY HYPERPARATHYROIDISM |
| Íñigo Santamaría,1 Rosa Jofré,2 José Ramón Polo,2 Javier Menárguez,2 Jorge Cannata-Andía.1 |
| 1Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, Oviedo, Spain; 2Nephrology, Endocrinology and Pathology Unit, Hospital Gregorio Marañon, Madrid, Spain |
| PTHrP 1-40 RAPIDLY ENHANCES THE PTH SECRETION IN RESPONSE TO HYPOCALCEMIA, BUT HAS NO EFFECT ON CaR, PTH, PTH/PTHrP RECEPTOR OR PTHrP GENE EXPRESSIONS IN VIVO IN THE RAT |
| Jinxing Huan,1 Ewa Lewin,2 Lars Bo Nielsen,3 Klaus Olgaard.1 |
| 1Dept Nephrology P2131, Rigshospitalet, Univ Copenhagen, Copenhagen, Denmark; 2Dept Nephrology B, Herlev Hospital, Univ Copenhagen, Herlev, Denmark; 3Dept Clinical Chemistry, Rigshospitalet, Univ Copenhagen, Copenhagen, Denmark |
| INTRAVENOUS CALCITRIOL THERAPY INCREASES SERUM CONCENTRATUS OF FGF-23 IN DIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM |
| Hiroshi Nishi,1 Tomoko Kono-Nii,1 Yuji Yamazaki,2 Takeyoshi Yamashita,2 Seiji Fukumoto,3 Akira Fujimori,4 Masafumi Fukagawa.1 |
| 1Div Nephrology and Dialysis Center, Kobe Univ Grad School Medicine, Kobe, Hyogo, Japan; 2Pharmaceutical Research Lab, Pharmaceutical Div, Kirin Brewery Co, Takasaki, Gunma, Japan; 3Dept Lab Medicine, Univ Tokyo, Tokyo, Japan; 4Dept Artificial Kidney, Konan Hosp, Kobe, Hyogo, Japan |
| MECHANISMS OF ALUMINUM-INDUCED PTH INHIBITION: ROLE OF THE CALCIUM-SENSING RECEPTOR |
| Ignacio González-Suárez, Manuel Naves-Díaz, Maria Teresa Fernández-Coto, Primitiva Menéndez-Rodríguez, José Luis Fernández-Martín, Jorge Cannata-Andía. |
| Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, Oviedo, Spain |
| back to the top |
| HALL 4.Rossio 16:00 - 17:30 |
| Free Communication Session 6 |
| Cell turnover and fibrosis |
| Chair: M. De Broe, Antwerp, Belgium and A. Rees, Aberdeen, United Kingdom |
| APOPTOSIS OF GLOMERULAR CELLS CAUSES RENAL PARENCHYMAL DAMAGE IN EXPERIMENTAL NEPHRITIS |
| Zbigniew Hruby,1 Maciej Rosinski,2 Bronislaw Tyran.1 |
| 1Department of Nephrology, Wroclaw Medical University, Wroclaw, Poland; 2Regional Pediatric Hospital, Wroclaw, Poland |
| EFFECTS OF ESTROGEN ON THE APOPTOSIS INDUCED BY TESTOSTERONE IN HUMAN RENAL TUBULAR CELLS |
| Maria Teresa Gandolfo,1 Daniela Verzola,1 Francesca Salvatore,1 Vanessa Procopio,1 Fabio Gianiorio,1 Paolo Traverso,2 Barbara Villaggio,1 Giacomo Deferrari,1 Giacomo Garibotto.1 |
| 1Nephrology Division, University of Medicine, Genoa, Italy; 2Urology Division, University of Medicine, Genoa, Italy |
| ROLE OF REACTIVE OXYGEN SPECIES IN TGF-b1-INDUCED EPITHELIAL-MESENCHYMAL TRANSITION IN RENAL TUBULAR EPITHELIAL CELLS |
| Dong Young Rhyu, Yanqiang Yang, Hunjoo Ha, Hi Bahl Lee. |
| Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea |
| RENIN ANGIOTENSIN SYSTEM AND THE FIBROGENIC CASCADE IN ALLOGRAFT BIOPSIES: DONOR-RECIPIENT RAS GENOTYPING AND GENE EXPRESSION STUDIES |
| Dorella Del Prete,1 Romina Graziotto,1 Franca Anglani,1 Monica Ceol,1 Macarena Gomez-Lira,2 Alberto Turco,2 Maria Luisa Valente,3 Daniela Vianello,1 Nicola Baldan,4 Luciana Bonfante,1 Paolo Rigotti,4 Giovanni Gambaro,1 Angela D’Angelo.1 |
| 1Medical & Surgical Sciences, Univ Padua, Div Nephrology, Padua, Italy; 2Sect Genetics, Univ Verona, Verona, Italy; 3Inst Anatomy, Univ Padua, Padua, Italy; 4Medical & Surgical Sciences, Univ Padua, Padua, Italy |
| CONNETTIVE TISSUE GROWTH FACTOR (CTGF) IS ENHANCED IN CULTURED MESANGIAL CELLS BY ABERRANTLY GLYCOSYLATED IgA: POSSIBLE DIRECT ROLE OF MESANGIAL DEPOSIT OF IgA IN PROGRESSION OF IgA NEPHROPATHY |
| Alessandro Amore, Stefania Turcato, Laura Ghisellini, Monica Chiesa, Alessandra Mollo, Paola Cirina, Licia Peruzzi, Giovanni Conti, Rosanna Coppo. |
| Nephrology Dialysis Transplantation Dept, Regina Margherita Hospital, Torino, Italy |
| REGRESSION OF RENAL VASCULAR FIBROSIS BY RE-ACTIVATION OF NITRIC OXIDE SYNTHESIS |
| Jean-Jacques Boffa, Pierre-Louis Tharaux, Martin Flamant, Jean-Claude Dussaule, Christos Chatziantoniou. |
| Inserm U489, Tenon Hospital, Paris, France |
| back to the top |
| HALL 5.Estrela 16:00 - 17:30 |
| Free Communication Session 7 |
| Cardiovascular complications in CKD |
| Chair: T. Drüeke, Paris, France and J. Fort, Barcelona, Spain |
| INVOLVEMENT OF CD40-CD154 INTERACTION IN THE PATHOGENESIS OF ATHEROSCLEROSIS IN PATIENTS WITH END-STAGE RENAL FAILURE |
| Valentina Câmpean,1 Daniel Neureiter,1 Barbara Nonnast-Daniel,2 Christoph Garlichs,3 Marie-Luise Gross,4 Kerstin Amann.1 |
| 1Pathology, 2Internal Medicine IV, 3Internal Medicine II, University of Erlangen-Nürnberg, Erlangen, Germany; 4Pathology, University of Heidelberg, Heidelberg, Germany |
| ENDOTHELIAL CELL ADHESION MOLECULES AND CAROTID ATHEROSCLEROSIS IN END-STAGE RENAL DISEASE (ESRD) PATIENTS |
| Aikaterini Papagianni,1 Michalis Kalovoulos,2 Spyros Dovas,1 Dimitrios Kirmizis,1 Dominiki Economidou,1 Anna-Maria Belechri,1 Efstathios Alexopoulos,1 Georgios Grollios,2 Dimitrios Memmos.1 |
| 1University Department of Nephrology, Hippokration General Hospital, Thessaloniki, Greece; 2Department of Radiology, Hippokration General Hospital, Thessaloniki, Greece |
| THE MATRIX GLA PROTEIN-138 GENOTYPE IS ASSOCIATED WITH CLINICAL OUTCOME IN END-STAGE RENAL DISEASE PATIENTS |
| Kai Wang,1,2 Hirokazu Honda,1 Abuul Rashid Qureshi,1 Roberto Pecoits-Filho,1 Jonas Axelsson,1 Louise Nordfors,3 Martin Schalling,3 Catherine M. Hoff,4 Clifford J. Holmes,4 Olof Heimburger,1 Peter Stenvinkel,1 Bengt Lindholm.1 |
| 1Div Renal Medicine & Baxter Novum, Dept Clinical Science, Huddinge Univ Hosp, Karolinska Inst, Stockholm, Sweden; 2Div Renal Medicine, Renji Hosp, Shanghai Second Medical Univ, Shanghai, China; 3Dept Molecular Medicine, Karolinska Inst, Stockholm, Sweden; 4Renal Div Scientific Affairs, McGaw Park, Baxter Healthcare Corporation, IL, United States |
| HDL ANTIOXIDANT FUNCTION IS ASSOCIATED WITH RENAL FUNCTION BUT NOT PARAOXONASE GENOTYPE OR ACTIVITY |
| Craig Nelson,1,2 David Packham,2 Gavin Becker,2 James Best,1 Alicia Jenkins.1 |
| 1Department of Medicine, St Vincent’s Hospital, Melbourne, VIC, Australia; 2Department of Nephrology, Royal Melbourne Hospital, Melbourne, VIC, Australia |
| PREVALENCE AND PREDICTORS OF LEFT VENTRICULAR HYPERTROPHY IN CHRONIC KIDNEY DISEASE |
| Ernesto Paoletti,1 Diego Bellino,1 Paolo Cassottana,2 Beatrice Damasio,1 Giuseppe Cannella.1 |
| 1Divisione di Nefrologia, Dialisi e Trapianto, Az. Ospedale S. Martino, Genova, Italy; 2Divisione di Cardiologia, Az. Osedale S. Martino, Genova, Italy |
| CORRELATION BETWEEN SOLUBLE ADHESION MOLECULES, TNF-a MALNUTRITION AND INFLAMMATION IN RENAL PATIENTS |
| Francesco Vaccaro, Maurizio Soresi, Lidia Giannitrapani, Francesco Paolo Picone, Santina Cottone, Anna Vadalà, Vito Sparacino, Sergio Calabrese, Giuseppe Montalto. |
| Internal Medicine, Cardiovascular and Renal Disease, Chair of Internal Medicine, Univ Palermo, Palermo, Italy; Chair of Internal Medicine, Univ Palermo, Palermo, Italy; Division of Nephrology with Transplantation, Civico Hospital, Palermo, Italy |
| back to the top |
Monday, May 17
| HALL 2.Baixa 09:00 - 10:30 |
| Free Communication Session 8 |
| Transplantation (2) |
| Chair: J.D. Briggs, Glasgow, United Kingdom and Y. Vanrenterghem, Leuven, Belgium |
| DOES DOBUTAMINE STRESS ECHOCARDIOGRAPHY (DSE) OBVIATE THE NEED OF CORONARY ANGIOGRAPHY (CA) IN TYPE II DIABETIC (DM) PATIENT BEING EVALUATED FOR RENAL TRANSPLANTATION? |
| Sishir Gang, Manish Dabhi, Mohan Rajapurkar. |
| Department of Nephrology, Muljibhai Patel Society for Research in Nephro-Urology, Nadiad, Gujarat, India |
| ELEVATED PLASMA TOTAL-HOMOCYSTEINE PREDICTS PATIENT AND ALLOGRAFT SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS |
| Wolfgang C. Winkelmayer,1 Reinhard Kramar,2 Gere Sunder-Plassmann.3 |
| 1Div Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hosp, Boston, MA, USA; 2Austrian Dialysis and Transplant Registry, Krankenhaus der Kreuzschwestern Wels, Wels, Austria; 3Div Nephrology and Dialysis, Vienna Univ School of Medicine, Vienna, Austria |
| KIDNEY TRANSPLANTS PATIENTS TREATED WITH ANTI-IL-2 ALPHA CHAIN RECEPTOR ANTIBODY DISPLAY DOWNREGULATED TOLL-LIKE RECEPTORS 4 AND 9 IN FINE-NEEDLE ASPIRATION BIOPSY SAMPLES |
| Carla Santos,1 Roberto Roncon-Albuquerque,2 Adelino Moreira,2 Susana Sampaio,1 Paula Xavier,3 Manuel Pestana,1 José Gerardo Oliveira.1 |
| 1Nephrology, Faculdade de Medicina Da Up, Porto, Portugal; 2Physiology, Faculdade de Medicina Da Up, Porto, Portugal; 3Centro de Histocompatibilidade do Norte, Lusotransplante, Porto, Portugal |
| COMPARATIVE ANALYSIS OF RENAL FUNCTION IN PATIENTS WITH CADAVERIC KIDNEY TRANSPLANTS TREATED WITH TACROLIMUS OR CYCLOSPORINE |
| M. González Molina,1 J. Morales,2 R. Marcén,3 D. Del Castillo,4 J. Grinyo,5 S. Gil-Vernet,5 F. Oppenheimer,6 J. Campistol,6 L. Capdevila,7 I. Lampreave,8 F. Valdés,9 A. Andrés,2 F. Anaya,10 F. Escuin,11 M. Arias,12 L. Pallardó,13 (Spanish Renal Forum). |
| 1Dept Nephrology, Hosp Univ Carlos Haya Malaga, Spain; 2Dept Nephrology, Hosp 12 Octubre Madrid, Spain; 3Dept Nephrology, Hosp Ramon y Cajal Madrid, Spain; 4Dept Nephrology, Hosp Reina Sofia Cordoba, Spain; 5Dept Nephrology, Hosp Bellvitge Barcelona, Spain; 6Dept Nephrology, Hosp Clinic, Barcelona, Spain; 7Dept Nephrology, Hosp Val d’Hebron, Barcelona, Spain; 8Dept Nephrology, Hosp Cruces, Bilbao, Spain; 9Dept Nephrology, Hosp Juan Canalejo, A Coruna, Spain; 10Dept Nephrology, Hosp Gregorio Marañón, Madrid, Spain; 11Dept Nephrology, Hosp La Paz, Madrid, Spain; 12Dept Nephrology, Hosp Valdecilla, Santander, Spain; 13Dept Nephrology, Hosp Doctor Peset, Valencia, Spain |
| 48-MONTH RESULTS OF SIROLIMUS-BASED THERAPY FOLLOWING EARLY CYCLOSPORINE WITHDRAWAL DEMONSTRATE SUPERIOR RENAL ALLOGRAFT SURVIVAL |
| Jose M. Morales, Henri Kreis, Rainer Oberbauer, Josep M. Campistol, Alfredo Mota, Antonio C. Henriques, Reimao Pinto, Juan Carlos Ruiz, Giuseppe Nanni, Anders Hartmann, Wolfgang Arns, the Rapamune Maintenance Regimen Study Group. |
| Hospital 12 de Octubre, Madrid, Spain |
| EDUCATIONAL PROGRAM TO REDUCE NONCOMPLIANCE AFTER RENAL TRANSPLANTATION |
| Nathalie Breu Dejean,1 Lionel Rontaing,2 Maryse Lapeyre-Mestre,3 Bernadette Roge,1 Dominique Durand.2 |
| 1Clinical Psychopathology, Human Sciences University, Toulouse, France; 2Multiorgan Transplant Unit, University Hospital, Toulouse, France; 3Clinical Pharmacology, University Hospital, Toulouse, France |
| back to the top |
| HALL 4.Rossio 09:00 - 10:30 |
| Free Communication Session 9 |
| Hypertension and heart disease in dialysis patients |
| Chair: F. Kokot, Katowice, Poland and P. Ponce, Almada, Portugal |
| BLOOD PRESSURE EVALUATION IN HEMODIALYSIS PATIENTS: ESTIMATION OF A RELIABLE METHOD |
| Riccardo Maria Fagugli, Giovanni Ciao, Beatrice Cicconi. |
| Nephrology-Dialysis, Azienda Ospedaliera di Perugia, Perugia, Italy |
| 24 HOURS BLOOD PRESSURE (24h BP) COMPONENTS AND LONG-TERM SURVIVAL IN END-STAGE RENAL DISEASE (ESRD) PATIENTS: THR ROLE OF BLOOD PRESSURE VARIABILITY (BPV) |
| Giovanni Galli, Cinzia Caselli, Paolo Cicinato,Grazia Iez, Patrizia Klein, Roberta Zanchi, Giovanni Panzetta. |
| Nefrologia e Dialisi, Azienda Ospedaliera Ospedali Riuniti Trieste, Trieste, Italy |
| PROGNOSTIC VALUE OF HEART FAILURE (NYHA CLASSIFICATION) AND OF MULTIFACTORIAL RISK SCORE METHODS IN ESRD PATIENTS |
| Maurizio Postorino, Carmen Marino, Giovanni Tripepi, Carmine Zoccali, Working Group of Calabrian Registry of Uremia and Dialysis. |
| CNR-IBIM, National Research Council Institute of Biomedicine, Clinical Epidemiology and Physiopathology of Renal Disease and Hypertension, Reggio Calabria, Italy |
| THE EFFECT OF CHANGES IN SALT AND WATER BALANCE ON BRAIN NATRIURETIC PEPTIDE IN CHRONIC HAEMODIALYSIS PATIENTS |
| Stewart Lambie, Maarten Taal, Richard Fluck, Christopher McIntyre. |
| Renal Unit, Centre for Integrated Studies Biology and Medicine, Derby City General Hospital, Derby, United Kingdom |
| IODINE-123-BMIPP IMAGING IN MAINTENANCE HEMODIALYSIS PATIENTS: A GUIDE FOR INTERVENTIONAL STRATEGY |
| Masato Nishimura,1 Tetsuya Hashimoto,2 Hiroyuki Kobayashi,2 Toyofumi Fukuda,2 Koji Okino,3 Noriyuki Yamamoto,2 Hiroshi Fujita,4 Naoto Inoue,4 Toshihiko Ono.2 |
| 1Cardiovascular Division, 2Department of Urology, 3Department of Surgery, Toujinkai Hospital, Kyoto, Kyoto, Japan; 4Department of Interventional Cardiology, Kyoto Second Red Cross Hospital, Kyoto, Kyoto, Japan |
| THE EFFECT OF HIGHER HAEMOGLOBIN LEVELS ON LEFT VENTRICULAR CAVITY VOLUME IN PATIENTS STARTING HAEMODIALYSIS: A BLINDED, RANDOMISED, CONTROLLED TRIAL IN 596 PATIENTS WITHOUT SYMPTOMATIC CARDIAC DISEASE |
| R.N. Foley,1 P.S. Parfrey,2 B.H. Wittreich,3 D.J. Sullivan,3 M.J. Zagari,3 D. Frei,3 The Canadian European Study Group. |
| 1Nephrology Analytical Services, University of Minnesota, Minneapolis, MN, United States; 2Division of Nephrology, Memorial University, St. John’s, NL, Canada; 3Pharmaceutical Research and Development, LLC, Johnson & Johnson, Raritan, NJ, United States |
| back to the top |
| HALL 3.Lapa 13:30 - 15:00 |
| Free Communication Session 10 |
| Bone disease and Calcimimetics |
| Chair: J. Cunningham, London, United Kingdom and A.L.M. De Francisco, Santander, Spain |
| RISK FACTORS FOR OSTEOPENIA IN CHRONIC HEMODIALYSIS PATIENTS. A HISTOMORPHOMETRIC STUDY |
| Fellype C. Barreto,1 Daniela V. Barreto,1 Rosa A. Moysés,2 Vanda Jorgetti,2 Maria Eugenia F. Canziani,1 Aluizio B. Carvalho.1 |
| 1Nephrology Division, Federal University of São Paulo; 2University of São Paulo, São Paulo, SP, Brazil |
| THE SKELETAL SENSITIVITY OF PTH VIEWED FROM SERUM NTx AND ITS DEPENDENCY ON ESTRADIOL IN HEMODIALIZED PATIENTS |
| Takayuki Hamano,1 Susumu Oseto,1 Takahito Ito,1 Masaya Katayama,2 Masaru Horio,1 Enyu Imai,1 Masatsugu Horio.1 |
| 1Department of Internal Medicine and Therapeutics, Osaka University, Suita, Osaka, Japan; 2The Second Rokushima Clinic, Amagasaki, Hyougo, Japan |
| DIFFERENTIAL EFFECTS OF TREATMENTS WITH ESTROGEN AND RALOXIFENE ON BONE AND LIPID METABOLISM IN RATS WITH CHRONIC RENAL FAILURE AND ESTROGEN INSUFFICIENCY |
| Manuel Naves, Aránzazu Rodríguez-Rodríguez, Mercedes Serrano, Angeles González-Carcedo, Ana Rodríguez-Rebollar, Jorge Cannata-Andía. |
| Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, Oviedo, Spain |
| CINACALCET HCL REDUCES BONE TURNOVER AND BONE MARROW FIBROSIS IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM (HPT) |
| H.H. Malluche,1 M.C. Monier-Faugere,1 G. Wang,1 J.M. Frazao,2 C. Charytan,3 J.W. Coburn,4 D.W. Coyne,5 M.R. Kaplan,6 N. Baker,7 L.C. McCary,7 S.A. Turner,7 W.G. Goodman.8 |
| 1Univ Kentucky Med Ctr, Lexington, KY; 2Centro Renal-Agrupamento Médico Tratamento Doenças Renais & Sch Med, Univ Porto, Portugal; 3New York Hosp Med Ctr Queens, Flushing, NY; 4VAMC, Los Angeles, CA; 5Washington Univ Sch Med, St Louis, MO; 6Neph Assoc, Nashville, TN; 7Amgen Inc, Thousand Oaks, CA; 8UCLA Sch of Med, Los Angeles, CA |
| THE EFFECT OF CINACALCET HCL ON PARATHYROIDECTOMY, FRACTURE, HOSPITALIZATION, AND MORTALITY IN DIALYSIS SUBJECTS WITH SECONDARY HYPERPARATHYROIDISM (HPT) |
| J. Cunningham,1 G. Chertow,2 W. Goodman,3 M. Danese,4 K. Olson,4 P. Klassen,4 T. Drüeke.5 |
| 1Royal London Hospital, London, United Kingdom; 2UCSF School of Medicine, San Francisco, CA; 3UCLA School of Medicine, Los Angeles, CA; 4Amgen Inc, Thousand Oaks, CA; 5Necker Hospital, Paris, France |
| CINACALCET HCl EFFECTIVELY REDUCES INTACT PARATHYROID HORMONE (iPTH) AND Ca x P IRRESPECTIVE OF THE SEVERITY OF SECONDARY HYPERPARATHYROIDISM (HPT) |
| J.M. Frazao,1 M. Nicolini,2 J.V. Torregrossa,3 P. Kerr,4 P.H. Jaeger,5 S.M. Sprague,6 M. Jadoul,7 G. Mellotte,8 U. Neyer,9 H. Geiger,10 E.C. Hagen,11 L. McCary,12 N. Baker,12 S. Turner,12 L.D. Quarles.13 |
| 1Centro Agrupamento Medico para o Tratamento de Doencas Renais and School of Medicine, Porto, Portugal; 2Osp Civile S. Andrea, La Spezia, Italy; 3Hosp Clinic i Centre Hosp Nice, France; 4Evanston Hosp, Evanston, IL, USA; 5Cliniques Univ Saint Luc, Brussels, Belgium; 6Adelaide and Meath Hosp, Dublin, Ireland; 7Landeskrankenhaus Feldkirch, Feldkirch, Austria; 8Johann-Wolfgang-Goethe-Univ, Frankfurt, Germany; 9Meander Medisch Centrum, Amersfoort, Netherlands; 10Amgen Inc, Thousand Oaks, United States; 11Duke Univ Medical Center, Durham, NC, United States |
| back to the top |
| HALL 4.Rossio 13:30 - 15:00 |
| Free Communication Session 11 |
| Mediators of renal disease |
| Chair: J. Floege, Aachen, Germany and P. Mathieson, Bristol, United Kingdom |
| EXPRESSION OF HYPOXIA INDUCIBLE TRANSCRIPTION FACTORS IN POLYCYSTIC KIDNEY DISEASE |
| Wanja Griethe,1 Norbert Gretz,2 Christian Rosenberger,1 Roland Schmitt,3 Wilko Weichert,4 Ulrich Frei,1 Sebastian Bachmann,3 Michael S. Wiesener,1 Kai-Uwe Eckardt.1 |
| 1Dept Nephrology and Medical Intensive Care, Univ Hosp Charite-Campus Virchow, Berlin, Germany; 2Medical Res Centre, Klinikum Mannheim, Univ Heidelberg, Mannheim, Germany; 3Inst Anatomy, Humboldt Univ, Berlin, Germany; 4Inst Pathology, Univ Hosp Charite-Campus-Mitte, Berlin, Germany |
| SIGNIFICANCE OF A SELECTIVE HYDROXYL FREE RADICAL MARKER, THE URINARY ORTHO-/PARA-TYROSINE QUOTIENT IN DIABETIC, DIABETIC-AZOTAEMIC AND NON-DIABETIC AZOTAEMIC PATIENTS |
| Gergo A. Molnár,1 Zoltán Wagner,1 László Wagner,1 Mónika Tamaskó,1 Boglárka Laczy,1 Zoltán Matus,2 Béla Kocsis,3 Tamás Koszegi,4 Rosemarie Kientsch-Engel,5 Péter Degrell,1 Judit Nagy,1 István Wittmann.1 |
| 1Second Dept Medicine & Nephrological Center, 2Dept Medical Chemistry & Biochemistry, 3Dept Microbiology & Immunology, 4Dept Clinical Chemistry, Univ Pécs, Medical Faculty, Pécs, Hungary; 5Roche Diagnostics GmbH, Penzberg, Germany |
| PTH STIMULATES ENDOTHELIAL CELLS eNOS EXPRESSION |
| Dina Fishman,2 Gloria Rashid,1 Elenora Plotkin,1 Jacques Bernheim.1,2 |
| 1Nephrology and Hypertension, Sapir Medical Center, Kfar-Saba, Israel; 2Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel |
| DIFFERENT BIOLOGICAL RESPONSES TO PLATELET DERIVED GROWTH FACTOR (PDGF)-B AND -D IN HUMAN MESANGIAL CELLS (HMC) |
| Claudia van Roeyen,1 Tammo Ostendorf,1 Dirk Bokemeyer,2 Iris Behrmann,3 Frank Strutz,4 Henri S. Lichenstein,5 William J. LaRochelle,5 Juergen Floege.1 |
| 1Div. of Nephrology, University of Aachen, Aachen, Germany; 2Div. of Nephrology, Augusta-Kranken-Anstalt, Bochum, Germany; 3Inst. of Biochemistry, University of Aachen, Aachen, Germany; 4Div. of Nephrology, University of Göttingen, Göttingen, Germany; 5CuraGen Corporation, Branford, CT, United States |
| THE CHEMOKINE SLC/CCL21 AND ITS RECEPTOR CCR7 CONTROLS THE ADHESION OF HUMAN MESANGIAL CELLS TO SURROUNDING MATRIX |
| Bernhard Banas,1 Markus Wornle,2 Monika Merkle,2 Holger Schmid,2 Miriam Pietrzyk,1 Bernhard Kramer,1 Detlef Schlondorff.2 |
| 1Klinik und Poliklinik fur Innere Medizin II, University of Regensburg, Regensburg, Germany; 2Medizinische Poliklinik, University of Munich, Munich, Germany |
| VEGF-A SIGNALING IN THE GLOMERULUS |
| Vera Eremina,1 Jody Haigh,1 Andras Nagy,1 Susan E. Quaggin.1,2 |
| 1Maternal and Fetal Health, The Sumuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada; 2Division of Nephrology, St. Mike’s Hospital, University of Toronto, Toronto, ON, Canada |
| back to the top |
| HALL 5.Estrela 13:30 - 15:00 |
| Free Communication Session 12 |
| Glomerulonephritis and systemic diseases |
| Chair: J. Feehally, Leicester, United Kingdom and R. Alves, Coimbra, Portugal |
| CONGENITAL NEPHROTIC SYNDROME: MOLECULAR ANALYSIS OF NPHS1 AND NPHS2 GENES IN ITALIAN FAMILIES AND DETECTION OF NEW MUTATIONS |
| Maddalena Gigante,1 Achille Iolascon,2 Vincenza Defazio,1 Eustacchio Montemurno,1 Massimo Papale,1 Loreto Gesualdo.1 |
| 1Scienze Biomediche - Nephrology Section, University of Foggia, Foggia, Italy; 2Scienze Mediche e del Lavoro - Pediatrics Section, University of Foggia, Foggia, Italy |
| TRUNCATING MUTATIONS IN MME GENE CAUSE FETO-MATERNAL ALLO-IMMUNIZATION AND NEONATAL GLOMERULOPATHIES |
| Hanna Debiec,1 Jeroen Nauta,2 Florence Coulet,3 Mirjam van der Burg,4 Vincent Guigonis,5 Thierry Schurmans,6 Emile de Heer,7 Florent Soubrier,3 Francoise Janssen,6 Pierre Ronco.1 |
| 1INSERM U489, Tenon Hosp, Paris, France; 2Dept Pediatric Nephrology, Erasmus MC Sophia, Rotterdam, Netherlands; 3Dept Human Genetics, Tenon Hosp, Paris, France; 4Dept Immunology, Erasmus MC Sophia, Rotterdam, Netherlands; 5Dept Pediatric Nephrology, Armand-Trusseau Hosp, Paris, France; 6Dept Pedriatric Nephrology, Brussels Free Univ, Brussels, Belgium; 7Dept Pathology, Leiden Univ, Leiden, Netherlands |
| STEROIDS PLUS RAMIPRIL VERSUS RAMIPRIL ALONE IN THE TREATMENT OF IgA NEPHROPATHY: INTERIM ANALYSIS OF A PROSPECTIVE, CONTROLLED, RANDOMIZED, MULTICENTER TRIAL |
| D. Torres,1 M. Rossini,1 C. Manno,1 L. Gesualdo,2 G. Grandaliano,1 F.P. Schena,1 on Behalf of the EPRAN Study Group. |
| 1Div of Nephrology, DETO, University of Bari; 2Chair of Nephrology, University of Foggia, Italy |
| PROGNOSTIC FACTORS IN RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS (RPGN) |
| Lazaros Gionanlis,1 Efstathios Alexopoulos,1 Maria Leontsini,2 Ekaterini Papagianni,1 Dimitrios Memmos.1 |
| 1Department of Nephrology, Hippokration General Hospital, Thessaloniki, Thessaloniki, Greece; 2Department of Pathology, Hippokration General Hospital, Thessaloniki, Thessaloniki, Greece |
| ANALYSIS OF PROTEINURIA AS A RISK FACTOR FOR LONG-TERM RENAL OUTCOME IN A CHRONIC RENAL DISEASE: EXAMPLE OF HENOCH-SCHÖNLEIN PURPURA NEPHRITIS (ITALIAN GROUP OF RENAL IMMUNOPATHOLOGY) |
| Rosanna Coppo,1 Simeone Andrulli,2 Bruno Gianoglio,1 Giovanni Conti,1 Alessandro Amore.1 |
| 1Nephrology Dialysis Transplantation, Regina Margherita Hospital, Torino, Italy; 2Nephrology Dialysis, A Manzoni Hospital, Lecco, Italy |
| A RANDOMIZED TRIAL COMPARING CYCLOSPORINE VERSUS AZATHIOPRINE FOR MAINTENANCE THERAPY IN DIFFUSE LUPUS NEPHRITIS |
| Gabriella Moroni,1 Andrea Doria,2 Marta Mosca,3 Giovanni Ferraccioli,4 Silvio Todesco,2 Francesco Paolo Schena,5 Paolo Altieri,6 Roberto Ferrara,7 Ornella Della Casa,7 Claudio Ponticelli.1 |
| 1Div Nefrologia e Dialisi, Osp Maggiore Policlinico, Milano, Italy; 2Div Reumatologia, Univ Padova, Padova, Italy; 3Unità Reumatologia, Dip Medicina Interna, Univ Pisa, Pisa, Italy; 4Cattedra e Clinica Reumatologia, Policlinico Univ Udine, Udine, Italy; 5Div Nefrologia, Policlinico di Bari, Bari, Italy; 6Dip Nefrologia, Osp San Michele, Cagliari, Italy; 7Novartis, Origgio, Italy |
| back to the top |
| HALL 3.Lapa 15:30 - 17:00 |
| Free Communication Session 13 |
| From basics to clinical practice |
| Chair: A. Basci, Izmir, Turkey and J.P. Oliveira, Porto, Portugal |
| MICROINFLAMMATION BLUNTS THE SENSITIVITY OF POTASSIUM AND AMINO ACID METABOLISM TO GROWTH HORMONE IN PATIENTS WITH ADVANCED CHRONIC RENAL DISEASE |
| Giacomo Garibotto,1 Antonella Sofia,1 Vanessa Procopio,1 Valeria Cappelli,1 Alice Tarroni,1 Francesca Aloisi,1 Marika Arvigo,2 E. Ferrari,2 Antonella Barreca.2 |
| 1Dept of Intern Med Nephrol Div, Genoa Univ, Genoa, Italy; 2Dept of Endocrin and Metab, Genoa Univ, Genoa, Italy |
| INCREASED TOTAL NUMBER BUT IMPAIRED MIGRATORY ACTIVITY AND ADHESION OF ENDOTHELIAL PROGENITOR CELLS IN PATIENTS ON CHRONIC HEMODIALYSIS |
| Kay Herbrig,1 Frank Pistrosch,1 Uta Oelschlaegel,2 Andrea Wagner,1 Gunnar Wichmann,1 Peter Gross,1 Jens Passauer.1 |
| 1Department of Internal Medicine III/Nephrology, Technical University of Dresden, Dresden, Germany; 2Department of Internal Medicine/Haematology, Technical University of Dresden, Dresden, Germany |
| PRODUCTS OF NON ENZYMATIC GLYCOSYLATION OF ALBUMIN ACTIVATE THE NUCLEAR TRANSLOCATION OF THE TRANSCRIPTION FACTOR NF-kB IN MESOTHELIAL CELLS IN CULTURE |
| Alessandro Amore, Alessandra Mollo, Monica Chiesa, Giovanni Conti, Laura Ghisellini, Stefania Turcato, Paola Cirina, Licia Peruzzi, Rosanna Coppo. |
| Nephrology Dialysis Transplantation, Regina Margherita Hospital, Torino, Italy |
| EVALUATION OF THE PERITONEAL MEMBRANE PERMEABILITY AT PERITONEAL DIALYSIS (PD) ONSET AND LONGITUDINAL FOLLOW-UP |
| Gaëtan Clerbaux,1 Julie Francart,2 Pierre Wallemacq,3 Annie Robert,2 Eric Goffin.1 |
| 1Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; 2Biostatistics, Cliniques Universitaires Saint-Luc, Brussels, Belgium; 3Biochemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium |
| HEPATIC SUBCAPSULAR STEATOSIS AS A COMPLICATION IN DIABETIC PERITONEAL DIALYSIS PATIENTS ASSOCIATED WITH INTRAPERITONEAL INSULIN TREATMENT |
| Dilek Torun,1 Levent Oguzkurt,2 Siren Sezer,3 Aysegul Zumrutdal,1 Metin Singan,1 Ulku Adam,1 Fatma Nurhan Ozdemir,3 Mehmet Haberal.4 |
| 1Nephrology, 2Radiology, Baskent University Faculty of Medicine, Adana, Turkey; 3Nephrology, 4General Surgery, Baskent University Faculty of Medicine, Ankara, Turkey |
| NOCTURNAL HOME HAEMODIALYSIS IN THE NETHERLANDS |
| Menno Kooistra. |
| Dianet Dialysis Centres, Utrecht, Netherlands |
| back to the top |
| HALL 4.Rossio 15:30 - 17:00 |
| Free Communication Session 14 |
| Calcification and vascular disease in CKD |
| Chair: A. Hutchison, Manchester, United Kingdom and J.D. Barata, Carnaxide, Portugal |
| ISOLATED HYPERPHOSPHATEMIA DOES NOT CAUSE CARDIOVASCULAR CALCIFICATION, BUT IS ASSOCIATED WITH MYOCARDIAL CELL ACTIVATION IN EXPERIMENTAL CHRONIC RENAL FAILURE |
| Katia R. Neves,1 Fabiana G. Graciolli,1 Luciene M. dos Reis,1 Camile A. Pereira,1 Sabrina G. Oliveira,1 Carlos A. Pasqualucci,2 Irene L. Noronha,1 Rosa M. A. Moysés,1 Vanda Jorgetti.1 |
| 1Nephrology Division, University of São Paulo, São Paulo, SP, Brazil; 2Pathology Division, University of São Paulo, São Paulo, SP, Brazil |
| THE IMPACT OF FETUIN-A, PHOSPHATE AND UREMIA ON THE INDUCTION OF EXTRAOSSEOUS CALCIFICATION IN MICE |
| Ralf Westenfeld,1,2 Ralf Smeets,2 Cora Schaefer,2 Vincent Brandenburg,1,2 Jürgen Floege,1 Willi Jahnen-Dechent,2 Markus Ketteler.1 |
| 1Division of Nephrology and Immunology, University Hospital, Aachen, Germany; 2IZKF Biomat, University Hospital, Aachen, Germany |
| REDUCED BAROREFLEX SENSITIVITY IS ASSOCIATED WITH INCREASED VASCULAR CALCIFICATION AND ARTERIAL STIFFNESS |
| Lindsay Chesterton,1 Mhairi Sigrist,1 Terry Bennett,2 Chris McIntyre.1 |
| 1Department of Renal Medicine, Derby City General Hospital, Derby, United Kingdom; 2Centre for Integrated Systems Biology and Medicine, University of Nottingham, Nottingham, United Kingdom |
| RENAL TRANSPLANTATION AMELIORATES THE PROGRESSION OF ARTERIAL STIFFNESS AS MEASURED WITH AORTIC PULSE WAVE VELOCITY (AoPWV) IN ESRD PATIENTS |
| Tomasz Stompor,1 Marek Rajzer,2 Aldona Dembinska-Kiec,3 Kalina Kawecka-Jaszcz,2 Katarzyna Janda,1 Katarzyna Wojcik,1 Anna Zdzienicka,3 Wladyslaw Sulowicz.1 |
| 1Chair & Dept Nephrology, Medical Faculty, Jagiellonian University, Cracow, Poland; 2First Dept Cardiology, Medical Faculty, Jagiellonian University, Cracow, Poland; 3Dept Clinical Biochemistry, Medical Faculty, Jagiellonian University, Cracow, Poland |
| PLATELET-DERIVED DIADENOSINE POLYPHOSPHATES: POSSIBLE REASON OF THE INCREASE OF VASCULAR GROWTH IN HEMODIALYSIS PATIENTS? |
| Vera Jankowski, Markus van der Giet, Walter Zidek, Martin Tepel, Joachim Jankowski. |
| Med. Klinik IV, Charité - Campus Bejamin Franklin, Berlin, Germany |
| RISK FACTORS FOR LOWER LIMB AMPUTATIONS IN HAEMODIALYSIS PATIENTS |
| Anibal Ferreira,1,3 J. Kirchgessner,2,3 Daniele Marcelli.2,3 |
| 1Hemodial, Clínica de Diálise, Vila Franca de Xira, Portugal; 2Clinical Management Europe, Fresenius Medical Care, Bad Homburg, Germany; 3in Collaboration with All Fresenius Medical Care, Haemodialysis Centres from Portugal |
| back to the top |
| HALL 5.Estrela 15:30 - 17:00 |
| Free Communication Session 15 |
| Anaemia |
| Chair: I.C. Macdougall, London, United Kingdom and P. Barany, Stockholm, Sweden |
| DEVELOPMENT OF NOVEL ANIMAL MODELS OF PURE RED CELL APLASIA, ASSESSMENT OF THE AUTO EPO IMMUNOGLOBULINS AND EFFECTS OF DOSING |
| Jeanne Pistillo,1 Steve Elliott,1 Glenn Begley,1 John Ferbas,2 Cynthia Hartley,1 Tony Lorenzini,1 Angus Sinclair,1 Graham Molineux.1 |
| 1Hematology, Amgen Inc., Thousand Oaks, CA, United States; 2Clinical Immunology, Amgen Inc., Thousand Oaks, CA, United States |
| DETECTION OF BASELINE ANTI-ERYTHROPOIETIN ANTIBODIES IN PATIENTS WITH CHRONIC KIDNEY DISEASE, USING THE BIAcore IMMUNOASSAY |
| Steve Swanson. |
| Director of Clinical Immunology, Amgen Inc., Thousand Oaks, CA, United States |
| THE EFFECT OF HIGHER HAEMOGLOBIN LEVELS ON QUALITY OF LIFE IN PATIENTS STARTING HAEMODIALYSIS: A BLINDED, RANDOMISED, CONTROLLED TRIAL IN 596 PATIENTS WITHOUT SYMPTOMATIC CARDIAC DISEASE |
| P.S. Parfrey,1 R.N. Foley,2 B.H. Wittreich,3 D.J. Sullivan,3 M.J. Zagari,3 D. Frei,3 The Canadian European Study Group. |
| 1Division of Nephrology, Memorial University, St John’s, NL, Canada; 2Nephrology Analytical Services, University of Minnesota, Minneapolis, MN, United States; 3Pharmaceutical Research and Development, LLC, Johnson & Johnson, Raritan, NJ, United States |
| A RANDOMISED STUDY OF WEEKLY SUBCUTANEOUS ARANESP AND NEORECORMON IN A LARGE UNSELECTED HAEMODIALYSIS COHORT, MANAGED WITH COMPUTER ASSISTED ANAEMIA ALGORITHMS |
| Cae Tolman,1 Donald Richardson,2 Cherry Bartlett,1 Eric Will.1 |
| 1Department of Renal Medicine, St James’s University Hospital, Leeds; 2Department of Renal Medicine, York District Hospital, York, United Kingdom |
| INTRAVENOUS CERA (CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR) ADMINISTERED ONCE WEEKLY OR ONCE EVERY 2 WEEKS MAINTAINS HAEMOGLOBIN LEVELS IN HAEMODIALYSIS PATIENTS WITH CHRONIC RENAL ANAEMIA |
| Anatole Besarab,1 Vinod Bansal,2 Steven Fishbane,3 Martin Lunde,4 Moro Salifu,5 Ulrich Beyer,6 Frank C. Dougherty,6 on Behalf of the BA16285 Study Group. |
| 1Div Nephrology & Hypertension, Henry Ford Hosp, Detroit, IL, United States; 2Div Nephrology, Loyola Univ Med Center, Maywood, IL, United States; 3Div Nephrology, Winthrop Univ Hospital, Mineola, NY, United States; 4Internal Medicine/Nephrology, Twin Cities Clinical Research, Arden Hills, MN, United States; 5Div Nephrology, SUNY Downstate Medical Center, Brooklyn, NY, United States; 6Pharma Development, F. Hoffmann-La Roche, Basel, Switzerland |
| ANEMIA IS PREVALENT AND LARGELY UNDERTREATED IN PATIENTS AFTER KIDNEY TRANSPLANTATION |
| Istvan Mucsi,1,2,3 Csaba Ambrus,2,3 Marta Novak,1,4 Lilla Szeifert,1 Agnes Kovacs,1 Judit Pap,1 Adam Remport,5 Miklos Zsolt Molnar.1,6 |
| 1Inst Behavioral Sciences, 2SE-Fresenius Medical Care Dialysis Center, 3First Dept Internal Medicine, Semmelweis Univ Budapest, Hungary; 4Dept Psychiatry, Univ Toronto, Toronto, Canada; 5Dept Transplantation & Surgery, Semmelweis Univ Budapest, Hungary; 6Second Dept Internal Medicine, St. Margaret Hospital, Budapest, Hungary |
| back to the top |
Tuesday, May 18
| HALL 2.Baixa 09:00 - 10:30 |
| Free Communication Session 16 |
| Hypertension and renal failure: experimental data |
| Chair: D. Tsakiris, Thessaloniki, Greece and J. Luño, Madrid, Spain |
| LOCAL EXPRESSION OF ANGIOTENSIN-CONVERTING ENZYME AND THE HOMOLOGUE, ANGIOTENSIN-CONVERTING ENZYME 2 IN HUMAN KIDNEY |
| Shigeyuki Wakahara,1 Tadashi Konoshita,1 Ichiro Koni,2 Isamu Miyamori.1 |
| 1Third Department of Internal Medicine, Fukui University School of Medicine, Matsuoka, Fukui, Japan; 2Second Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan |
| THE SUPEROXIDE DISMUTASE (SOD)-MIMETIC TEMPOL PREVENTS HYPERTENSION BY STIMULATING ENDOTHELIAL NOS ACTIVITY IN SYSTEMIC RESISTANCE ARTERIES OF 5/6 NEPHRECTOMIZED RATS |
| Galit Hasdan, Janice Green, Jacques Bernheim, Mauro Rathaus. |
| Department of Nephrology and Hypertension, Meir Hospital, Sapir Med Ctr, Tel Aviv University, Kfar Saba, Israel |
| STATIN TREATMENT REDUCES GLOMERULAR INFLAMMATION AND INJURY IN MINERALOCORTICOID HYPERTENSION |
| Bernd Klanke,1 Roland Veelken,1 Andrea Hartner,2 Roland Schmieder,1 Karl Hilgers.1 |
| 1Medicine IV, University of Erlangen, Erlangen, Germany; 2Pediatrics, University of Erlangen, Erlangen, Germany |
| EVALUATION OF ELECTROLYTES AND WATER TRANSPORT MOLECULES IN THE DIABETIC KIDNEY |
| Daniela Vidotti, Olinda Ykuta, Mirian Boim. |
| Medicine - Nephrology Division, Universidade Federal de São Paulo, São Paulo, SP, Brazil |
| PLATELET-ACTIVATING FACTOR REDUCES NEPHRIN EXPRESSION IN HUMAN PODOCYTES |
| Sophie Doublier, Benedetta Bussolati, Tiziana Spatola, Giovanni Camussi. |
| Department of Internal Medicine, University of Turin, Center of Experimental Research and Medical Sciences (CERMS), Turin, Italy |
| GLOMERULAR OXIDATIVE DAMAGE AND PODOCYTE ALTERATIONS IN TYPE II DIABETIC NEPHROPATHY |
| M.P. Rastaldi,1 A. Calvetta,1 N. Calvaresi,1 S. Armelloni,1 M. Li,1 S. Berra,1 A. Corbelli,1 G. Mariani,2 L. Carneglia,2 G. Garibotto,3 T. Bertani,4 A. Fornasieri,5 F. Ferrario,5 G.C. Tonolo,6 R. Nosadini,6 H. Holthofer,7 G. D’Amico.1 |
| 1Renal Immunopathology Lab, Associazione Nuova Nefrologia, Milan, Italy; 2Diabetology, San Carlo Hosp, Milan, Italy; 3Internal Medicine, Univ Genova, Genova, Italy; 4Nephrology, Ospedali Riuniti, Bergamo, Italy; 5Nephrology, San Carlo Hosp, Milan, Italy; 6Diabetology, Univ Sassari, Sassari, Italy; 7Technomedicum, Univ Helsinki, Helsinki, Finland |
| back to the top |
| HALL 4.Rossio 09:00 - 10:30 |
| Free Communication Session 17 |
| Diabetes mellitus: clinical studies |
| Chair: M. Riella, Curitiba, Brazil and H. Luz Rodrigues, Lisbon, Portugal |
| SERUM PARAOXONASE ACTIVITY AND PARAOXONASE GENE POLYMORPHISMS AN TYPE 2 DIABETIC PATIENTS WITH OR WITHOUT MICROVASCULAR COMPLICATIONS |
| Daniela Lucchesi,1 Laura Pucci,1 Vera Chirulli,2 Carmen Fotino,1 Stefano Triscornia,1 Roberto Miccoli,1 Erika Baldassari,1 Vincenzo Longo,2 Giuseppe Penno,1 Stefano Del Prato.1 |
| 1Endocrinology and Metabolism, University Hospital, Pisa, Italy; 2Clinical Physiology Institute, CNR, Pisa, Italy |
| TYPE 2 DIABETES AND OVERT NEPHROPATHY: USEFULNESS OF RENAL BIOPSY IN PREDICTING THE OUTCOME |
| Silvana Savoldi,1 Tullio Bertani,2 Gianna Mazzucco,3 Maria Pia Rastaldi,4 Tino Gesualdo,5 Piero Stratta,6 The Immunopathology Group of Italian Society of Nephrology.7 |
| 1SC Nephrology, Osp Riuniti, Trieste, Italy; 2Div Nephrology, Osp Riuniti, Bergamo, Italy; 3Dept Pathology, Univ Turin, Torino, Italy; 4Renal Immunopathology Lab, Ass Nuova Nefrologia, Milano, Italy; 5Chair Nephrology, Univ Foggia, Foggia, Italy; 6Dept Nephrology, Univ Turin, Torino, Italy |
| THE PREVALENCE OF DIFFERENT HISTOLOGIC PATTERNS IN TYPE 2 DIABETIC PATIENTS WITH OVERT NEPHROPATHY: THE RESULTS OF THE MULTICENTRIC STUDY OF THE ITALIAN GROUP OF IMMUNOPATHOLOGY (IGIP) |
| Tullio Bertani,1 Gianna Mazzucco,2 Maria Pia Rastaldi,3 Franco Ferrario,3 Giovanni Garibotto,4 Ferdinando Giordano,5 Piero Stratta,6 Guido Monga.7 |
| 1Div Nephrology, Osp Riuniti Bergamo, Bergamo, Italy; 2Pathology, Univ Torino, Torino, Italy; 3Div Nephrology, S Carlo Hosp Milano, Milano, Italy; 4Div Nephrology, Univ Genova, Genova, Italy; 5Pathology, Vimercate Hosp, Vimercate, Milano, Italy; 6Nephrology, Univ Novara, Novara, Italy; 7Pathology, Univ Novara, Novara, Italy |
| DYSLIPIDEMIC PHENOTYPES ASSOCIATE WITH NEPHROPATHY IN TYPE 1 DIABETES: THE ITALIAN COHORT OF THE EURODIAB IDDM COMPLICATIONS STUDY |
| Carmen Fotino,1 Daniela Lucchesi,1 Laura Pucci,1 Stefano Triscornia,1 Erika Baldassari,1 Giuseppe Penno,1 Roberto Miccoli,1 Stefano Del Prato,1 John Fuller.2 |
| 1Endocrinology and Metabolism, University Hospital, Pisa, Italy; 2Epidemiology and Public Health, University College, London, United Kingdom |
| CRP IN HEMODIALYSIS PATIENTS WITH DIABETES MELLITUS TYPE 2: A PREDICTOR FOR ALL CAUSE AND CARDIAC MORTALITY ONLY IN PATIENTS WITH FONTAINE STAGE IV PERIPHERAL ARTERIAL DISEASE |
| Carsten A. Böger,1 Martina Deinzer,2 Charalampos Aslanidis,2 Mike Stubanus,1 Bernhard Banas,1 Gerd Schmitz,2 Günter A.J. Riegger,1 Bernhard K. Krämer.1 |
| 1Nephrology, Klinik und Poliklinik für Innere Medizin II, Regensburg, Germany; 2Institut für Klinische Chemie und Laboratoriumsmedizin, Klinikum der Universität Regensburg, Regensburg, Germany |
| DE NOVO DIABETES MELLITUS AFTER RENAL TRANSPLANTATION: RISK FACTORS AND PROGNOSIS |
| Luis M. Pallardó, Eva Gavela, Asunción Sancho, Ana Avila, Jose F. Crespo, María Aparicio, Pablo Molina. |
| Nephrology Department, Hospital Universitario Dr. Peset, Valencia, Spain |
| back to the top |
| HALL 2.Baixa 11:00 - 12:30 |
| Free Communication Session 18 |